Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
Liu, Yang
Targeting IDH1-Mutated Malignancies with NRF2 Blockade. [electronic resource] - Journal of the National Cancer Institute 10 2019 - 1033-1041 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
1460-2105
10.1093/jnci/djy230 doi
Animals
Antineoplastic Agents--pharmacology
Antioxidants--pharmacology
Cell Line, Tumor
Disease Models, Animal
Genes, Reporter
Genetic Predisposition to Disease
Humans
Isocitrate Dehydrogenase--genetics
Mice
Models, Biological
Molecular Targeted Therapy
Mutation
NF-E2-Related Factor 2--antagonists & inhibitors
Neoplasms--drug therapy
Oxidation-Reduction
Reactive Oxygen Species--metabolism
Signal Transduction--drug effects
Xenograft Model Antitumor Assays
Targeting IDH1-Mutated Malignancies with NRF2 Blockade. [electronic resource] - Journal of the National Cancer Institute 10 2019 - 1033-1041 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Intramural
1460-2105
10.1093/jnci/djy230 doi
Animals
Antineoplastic Agents--pharmacology
Antioxidants--pharmacology
Cell Line, Tumor
Disease Models, Animal
Genes, Reporter
Genetic Predisposition to Disease
Humans
Isocitrate Dehydrogenase--genetics
Mice
Models, Biological
Molecular Targeted Therapy
Mutation
NF-E2-Related Factor 2--antagonists & inhibitors
Neoplasms--drug therapy
Oxidation-Reduction
Reactive Oxygen Species--metabolism
Signal Transduction--drug effects
Xenograft Model Antitumor Assays